Accelerate your submissions with an AI-native platform and deep regulatory expertise
Parexel and Weave are co-developing solutions that expedite regulatory submission preparation.
With Parexel’s proven regulatory expertise, combined with Weave’s cutting-edge technology as a pioneer in AI-native regulatory automation, we are targeting increased speed to market for new therapies.
We have already demonstrated results using Weave's flagship offering, AutoIND. Our teams complete Investigational New Drug (IND) drafting 50% faster than traditional authoring timelines, providing sponsors with a critical advantage in the time-sensitive process of launching clinical trials. AutoIND is now fully integrated into The Weave Platform—a comprehensive regulatory workflow solution supporting the entire regulatory submission lifecycle.
Parexel maintains a period of exclusivity as the only CRO implementing Weave's custom-designed AI templates that are created through our collaborative development process.
Case Study
Utilizing AI to deliver regulatory documents faster
Situation
Solution
Key achievements
- Parexel sought to accelerate regulatory document preparation (particularly INDs) to help customers initiate clinical trials faster, as traditional authoring took 8-10 weeks.
- The traditional manual review process of numerous source documents with raw data created potential for human error and regulatory discrepancies that could delay approvals.
Situation
- Parexel sought to accelerate regulatory document preparation (particularly INDs) to help customers initiate clinical trials faster, as traditional authoring took 8-10 weeks.
- The traditional manual review process of numerous source documents with raw data created potential for human error and regulatory discrepancies that could delay approvals.
Solution
Key achievements
"We’re beginning this partnership by addressing an area where sponsors feel extreme urgency – early regulatory authoring and submission preparation. By combining Weave's cutting-edge AI technology with the human-in-the-lead expertise of Parexel Consulting, we're helping teams move faster and with greater confidence while maintaining the highest levels of quality and compliance.”
-Paul Bridges, Ph.D.
President of Parexel Consulting
Together we want to improve speed and quality to bring therapies to patients faster.
Want to achieve up to 50% time savings for your IND draft authoring? See Parexel’s regulatory expertise and Weave’s AI authoring platform in action. Please get in touch, we’re always available for a conversation – and a demo.